Nektar Therapeutics
Clinical-stage biopharmaceutical company developing a pipeline of drug candidates. Learn more
Launch date
Employees
Market cap
$230m
Enterprise valuation
$71m (Public information from Sep 2024)
Share price
$1.27 NKTR
San Carlos California (HQ)
Authorizing premium user...